1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 114 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Aging of the nitric oxide system: are we as old as our NO?Sverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Horowitz, J.
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2018Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudyHorowitz, J.; De Caterina, R.; Heresztyn, T.; Alexander, J.; Andersson, U.; Lopes, R.; Steg, P.; Hylek, E.; Mohan, P.; Hanna, M.; Jansky, P.; Granger, C.; Wallentin, L.
2014High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialHijazi, Z.; Siegbahn, A.; Andersson, U.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Mohan, P.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
2013Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)Carrington, M.; Ball, J.; Horowitz, J.; Marwick, T.; Mahadevan, G.; Wong, C.; Abhayaratna, W.; Haluska, B.; Thompson, D.; Scuffham, P.; Stewart, S.
2014Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathySingh, K.; Carson, K.; Usmani, Z.; Sawhney, G.; Shah, R.; Horowitz, J.
2014Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathySingh, K.; Carson, K.; Shah, R.; Sawhney, G.; Singh, B.; Parsaik, A.; Gilutz, H.; Usmani, Z.; Horowitz, J.
2015Impaired platelet nitric oxide response in patients with new onset atrial fibrillationProcter, N.; Ball, J.; Liu, S.; Hurst, N.; Nooney, V.; Goh, V.; Stafford, I.; Heresztyn, T.; Carrington, M.; Ngo, D.; Hylek, E.; Isenberg, J.; Chirkov, Y.; Stewart, S.; Horowitz, J.
2014Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialWallentin, L.; Hijazi, Z.; Andersson, U.; Alexander, J.; De Caterina, R.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Åsberg, S.; Granger, C.; Siegbahn, A.
2016Can perhexiline be utilized without long-term toxicity? A clinical practice auditPhuong, H.; Choi, B.; Chong, C.; Raman, B.; Horowitz, J.

Discover